Barbara Sarholz

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

Mark T. J. van Bussel, Ahmad Awada, Maja J.A. de Jonge et al. · British Journal of Cancer · 2020 · 127 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Heterosis in early seed development: a comparative study of F1 embryo and endosperm tissues 6 days after fertilization

Stephanie Jahnke, Barbara Sarholz, Alexander Thiemann et al. · Theoretical and Applied Genetics · 2009 · 107 citations

Life Sciences, Developmental Biology, Genetics +14

Analysis of nonadditive protein accumulation in young primary roots of a maize ( <b> <i>Zea mays</i> </b> L.) F ₁ ‐hybrid compared to its parental inbred lines

Nadine Hoecker, Tobias Lamkemeyer, Barbara Sarholz et al. · PROTEOMICS · 2008 · 90 citations

Life Sciences, Plant Biology, Plant Sciences +14

Validation of candidate genes putatively associated with resistance to SCMV and MDMV in maize (Zea mays L.) by expression profiling

Anna Użarowska, Giuseppe Dionisio, Barbara Sarholz et al. · BMC Plant Biology · 2009 · 66 citations · Full text

Agriculture, Genetics, Plant Sciences +15

A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors

Michael A. Samuels, Johan Falkenius, Voichita Bar‐Ad et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15